| [1] |
McClune AC, Tong MJ. Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis, 2010,14:461-476.
|
| [2] |
Tsai WL,Chung RT. Viral hepatocarcinogenesis. Oncogene,2010,29:2309-2324.
|
| [3] |
Fang ZL, Sabin CA, Dong BQ, et al. HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Am J Gastroenterol,2008,103:2254-2262.
|
| [4] |
Chotiyaputta W, Lok AS. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol,2009,6:453-462.
|
| [5] |
Yuan JM, Ambinder A, Fan Y, et al. Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai,China. Cancer Epidemiol Biomarkers Prev,2009,18:590-594.
|
| [6] |
Ren XD, Lin SY, Wang X, et al. Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes. J Virol Methods,2009,158:24-29.
|
| [7] |
Chu CM, Karayiannis P, Fowler MJ, et al. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology,1985,5:431-434.
|
| [8] |
Kao JH. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatol Int,2007,1:415-430.
|
| [9] |
Dumpis U, Mendy M, Hill A, et al. Prevalence of HBV core promoter/precore/core muttious in Gambian chronic carriers. J Med Virol,2001,65: 664-670.
|
| [10] |
骆抗先. 乙型肝炎基础和临床. 北京:人民卫生出版社, 1997:241-244.
|
